Related Experiment Video
Updated: May 17, 2026

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
Published on: February 28, 2025
Ventricular arrhythmias and sudden cardiac death
Roy M John1, Usha B Tedrow, Bruce A Koplan
1Department of Medicine, Division of Cardiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. rjohn2@partners.org
Insights
Implantable cardioverter defibrillators (ICDs) manage ventricular arrhythmias and reduce sudden cardiac death. Catheter ablation and antiarrhythmic drugs help control symptoms and reduce arrhythmia frequency, improving patient outcomes.
Area of Science:
- Cardiology
- Electrophysiology
Background:
- Ventricular arrhythmias pose a risk of sudden cardiac death and symptom severity.
- Current management strategies balance risk stratification with therapeutic interventions.
Purpose of the Study:
- To review current management strategies for ventricular arrhythmias.
- To discuss the roles of implantable cardioverter defibrillators, antiarrhythmic drugs, catheter ablation, and surgery.
Main Methods:
- Review of existing literature on ventricular arrhythmia management.
- Analysis of the efficacy and limitations of various treatment modalities.
Main Results:
- Implantable cardioverter defibrillators (ICDs) are crucial for patients at high risk of sudden death.
- Antiarrhythmic drugs primarily manage symptomatic arrhythmias, while catheter ablation offers curative potential for select patients.
- Surgical interventions are reserved for refractory cases.
Conclusions:
- Advances in genetic understanding, mapping/ablation technology, and device algorithms enhance ventricular arrhythmia management.
- Integrated approaches combining devices, drugs, and ablation improve patient outcomes and reduce mortality.
Abstract:
Management strategies for ventricular arrhythmias are guided by the risk of sudden death and severity of symptoms. Patients with a substantial risk of sudden death usually need an implantable cardioverter defibrillator (ICD). Although ICDs effectively end most episodes of ventricular tachycardia or ventricular fibrillation and decrease mortality in specific populations of patients, they have inherent risks and limitations. Generally, antiarrhythmic drugs do not provide sufficient protection from sudden death, but do have a role in reducing arrhythmias that cause symptoms. Catheter ablation is likewise important for reducing the frequency of spontaneous arrhythmias and is curative for some patients, usually those with idiopathic arrhythmias and no heart disease. Arrhythmia surgery is now infrequent, offered by only a few specialised centres for refractory arrhythmias. Advances in understanding of genetic arrhythmia syndromes and in technology for mapping and ablation of ventricular arrhythmias, and enhanced algorithms in implantable devices for rhythm management, have contributed to improved outcomes.
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias II: Classification of Tachyarrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias III: Characteristics of Dysrhythmias
Dysrhythmias IV: Characteristics of Bradyarrhythmias
